These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28218440)

  • 1. Physiologically based kinetic modeling of hesperidin metabolism and its use to predict in vivo effective doses in humans.
    Boonpawa R; Spenkelink A; Punt A; Rietjens IMCM
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28218440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiologically based kinetic (PBK) model describing plasma concentrations of quercetin and its metabolites in rats.
    Boonpawa R; Spenkelink A; Rietjens IM; Punt A
    Biochem Pharmacol; 2014 May; 89(2):287-99. PubMed ID: 24561179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of orally administered water-dispersible hesperetin and its effect on peripheral vasodilatation in human subjects: implication of endothelial functions of plasma conjugated metabolites.
    Takumi H; Nakamura H; Simizu T; Harada R; Kometani T; Nadamoto T; Mukai R; Murota K; Kawai Y; Terao J
    Food Funct; 2012 Apr; 3(4):389-98. PubMed ID: 22307524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
    Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
    Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.
    Boonpawa R; Spenkelink A; Punt A; Rietjens IMCM
    Br J Pharmacol; 2017 Aug; 174(16):2739-2757. PubMed ID: 28585232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma.
    Matsumoto H; Ikoma Y; Sugiura M; Yano M; Hasegawa Y
    J Agric Food Chem; 2004 Oct; 52(21):6653-9. PubMed ID: 15479036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution of hesperetin in rats after a dietary intake.
    Takumi H; Mukai R; Ishiduka S; Kometani T; Terao J
    Biosci Biotechnol Biochem; 2011; 75(8):1608-10. PubMed ID: 21821945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability of glucosyl hesperidin in rats.
    Yamada M; Tanabe F; Arai N; Mitsuzumi H; Miwa Y; Kubota M; Chaen H; Kibata M
    Biosci Biotechnol Biochem; 2006 Jun; 70(6):1386-94. PubMed ID: 16794318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and Metabolic Behavior of Hesperidin (Rutinosylated Hesperetin) after Single Oral Administration to Sprague-Dawley Rats.
    Nectoux AM; Abe C; Huang SW; Ohno N; Tabata J; Miyata Y; Tanaka K; Tanaka T; Yamamura H; Matsui T
    J Agric Food Chem; 2019 Sep; 67(35):9812-9819. PubMed ID: 31392887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal absorption and metabolism of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside in healthy humans.
    Actis-Goretta L; Dew TP; Lévèques A; Pereira-Caro G; Rein M; Teml A; Schäfer C; Hofmann U; Schwab M; Eichelbaum M; Crozier A; Williamson G
    Mol Nutr Food Res; 2015 Sep; 59(9):1651-62. PubMed ID: 26018925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.
    Louisse J; de Jong E; van de Sandt JJ; Blaauboer BJ; Woutersen RA; Piersma AH; Rietjens IM; Verwei M
    Toxicol Sci; 2010 Dec; 118(2):470-84. PubMed ID: 20833708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of physiologically based kinetic (PBK) modeling to study interindividual human variation and species differences in plasma concentrations of quercetin and its metabolites.
    Boonpawa R; Moradi N; Spenkelink A; Rietjens IM; Punt A
    Biochem Pharmacol; 2015 Dec; 98(4):690-702. PubMed ID: 26441251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.
    Kanaze FI; Bounartzi MI; Georgarakis M; Niopas I
    Eur J Clin Nutr; 2007 Apr; 61(4):472-7. PubMed ID: 17047689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice.
    Manach C; Morand C; Gil-Izquierdo A; Bouteloup-Demange C; Rémésy C
    Eur J Clin Nutr; 2003 Feb; 57(2):235-42. PubMed ID: 12571654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose-response curves for developmental toxicity of phenol in rat and human.
    Strikwold M; Spenkelink B; Woutersen RA; Rietjens IM; Punt A
    Arch Toxicol; 2013 Sep; 87(9):1709-23. PubMed ID: 23943240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant and anti-inflammatory potential of hesperetin metabolites obtained from hesperetin-administered rat serum: an ex vivo approach.
    Yang HL; Chen SC; Senthil Kumar KJ; Yu KN; Lee Chao PD; Tsai SY; Hou YC; Hseu YC
    J Agric Food Chem; 2012 Jan; 60(1):522-32. PubMed ID: 22098419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
    Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
    Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Combined In Vitro Physiologically Based Kinetic (PBK) and Monte Carlo Modelling Approach to Predict Interindividual Human Variation in Phenol-Induced Developmental Toxicity.
    Strikwold M; Spenkelink B; Woutersen RA; Rietjens IMCM; Punt A
    Toxicol Sci; 2017 Jun; 157(2):365-376. PubMed ID: 28498972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangiferin and hesperidin metabolites are absorbed from the gastrointestinal tract of pigs after oral ingestion of a Cyclopia genistoides (honeybush tea) extract.
    Bock C; Waldmann KH; Ternes W
    Nutr Res; 2008 Dec; 28(12):879-91. PubMed ID: 19083501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Evaluation of In Vitro Hesperidin 2S Bioavailability in a Model Combining Luminal (Microbial) Digestion and Caco-2 Cell Absorption in Comparison to a Randomized Controlled Human Trial.
    Van Rymenant E; Salden B; Voorspoels S; Jacobs G; Noten B; Pitart J; Possemiers S; Smagghe G; Grootaert C; Van Camp J
    Mol Nutr Food Res; 2018 Apr; 62(8):e1700881. PubMed ID: 29451355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.